Enter your keywords
HOME
About Us
NEWSLETTER
To search AlzRisk, use the "Keyword" search on the
AlzRisk search page
.
NEWS
All News
Conference Coverage
Series
WEBINARS
All Webinars
Databases
AlzBiomarker
AlzPedia
AlzRisk
Antibodies
Genetics
AlzGene
HEX
Mutations
Protocols
Research Models
Therapeutics
PAPERS
All Papers
Papers of the Week
Milestone
Alzforum Recommends
PROFESSIONAL RESOURCES
Conference Calendar
Grants
Jobs
Member Directory
ABOUT AD
AD Overview
Early-Onset Familial
The HBO Alzheimer's Project
Supported Browsers
MY ALZFORUM
My AlzForum Home
View Library
View Notifications
Set Notifications
Edit Profile
AlzRisk Paper Detail
Risk Factors
Alcohol
B Vitamins
Blood Pressure
Cognitive Activity
Diabetes Mellitus
Dietary Pattern
Head injury
Homocysteine
Hormone Therapy
Inflammatory Biomarkers
Non-Steroidal Anti-Inflammatory Drugs
Nutritional Antioxidants
Obesity
Physical Activity
Statin use
Reference:
Ancelin, 2012
Cohort:
Three-City Study
Risk Factor:
Statin use
Average Follow-up Time Detail
Members of the cohort were followed for up to seven years. The article does not provide the average follow-up time for the male participants.
Exposure Detail
Interviewers ascertained exposure information by administrating a standardized questionnaire and by examining prescriptions and medications at baseline and at follow-up visits. The investigators reported results separately for male and female participants, and separately for statin use and fibrates use. This entry pertains to results among men and statin only use.
The investigators compared AD risk in two groups: the group of male participants who used statins at baseline ("Used") and the reference group of male participants who did not use statins or at baseline ("Did not use"). Within the entire study population of 7056 participants 16% reported using statins at their baseline evaluation, and another 13% reported using fibrates. The distribution of statin use status by sex was not reported.
Screening and Diagnosis Detail
Screening Method:
BVRT
Benton Visual Retention Test (Benton 1974)
IST
Isaacs' Set Test (Isaacs & Kennie 1973)
MMSE
Mini-Mental State Examination (Folstein 1975)
Neuropsych Testing
Other
TMT
Trail Making Test (Reitan 1958)
AD Diagnosis:
DSM IV
Diagnostic and Statistical Manual IV
NINCDS ADRDA
National Institute of Neurological and Communicative Diseases and Stroke/Alzheimer's Disease and Related Disorders Association Criteria (McKhann 1984)
Total dementia definition:
Dementia via DSM-IV
"A three-step procedure was used to diagnose cases of dementia. First, screening was based on a thorough neuropsychological examination by trained psychologists (see above). Data on activities of daily living, severity of cognitive disorders, and, where possible, magnetic resonance images or computed tomography scans were collected. In addition, in Montpellier and Bordeaux all participants were examined by a neurologist. In Dijon only persons suspected of having a cognitive deficit on the basis of their neuropsychological performance underwent further examination by a specialist. Finally, in the 3 centers, all suspected dementia cases were analyzed by a committee of neurologists according to DSM-IV criteria. The committee reviewed all potential cases of dementia to obtain a consensus on its diagnosis and etiology based on all available information. Alzheimer's disease was diagnosed according to National Institutes of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association criteria. The onset of dementia was the date of the follow-up interview when dementia was diagnosed."
Covariates & Analysis Detail
Analysis Type:
Cox proportional hazards regression
This analysis was restricted to male participants. Age was used as the time scale.
AD Covariates:
A
age
E
education
CC
city center
TD Covariates:
A
age
E
education
CC
city center